期刊文献+

卵巢浆液性肿瘤中Survivin和Caspase-3蛋白表达的相关性及其临床意义 被引量:1

Relationship of Survivin and Caspase-3 protein in ovarian serous tumors and their clinical significance
原文传递
导出
摘要 目的分析卵巢浆液性肿瘤中Survivin和Caspase-3蛋白的表达水平及相互关系,探讨二者在肿瘤发生、发展中的作用。方法应用流式细胞术定量检测43例卵巢组织标本中Survivin和Caspase-3蛋白的表达。结果卵巢浆液性囊腺癌中Survivin蛋白表达量高于正常组织和卵巢浆液性囊腺瘤,三者比较差异有统计学意义(F=19.80;P=0.00)。Survivin蛋白在早期卵巢浆液性囊腺癌中的表达量明显低于晚期,差异有统计学意义(t=2.882,P=0.009)。Survivin蛋白在高中分化和低分化的卵巢浆液性囊腺癌中的表达量比较差异无统计学意义(t=2.001,P=0.055)。Survivin蛋白在卵巢浆液性囊腺癌有无淋巴结转移组表达量的比较差异无统计学意义(t=0.318,P=0.912)。Caspase-3蛋白在卵巢浆液陛囊腺癌中的表达量明显低于卵巢浆液性囊腺瘤和正常卵巢组织,三者比较差异有统计学意义(F=16.32,P=0.00),且与卵巢浆液性囊腺癌的临床分期、组织学分级、淋巴结转移无关(P〉0.05)。survivin与Caspase-3蛋白的表达量呈负相关(r=-0.413,P=0.029)。结论Survivin和Caspase-3在卵巢浆液性肿瘤中的表达呈负相关,二者联合检测或可作为卵巢浆液性肿瘤辅助诊断及评价肿瘤恶性程度的参考指标。 Objective To investgate the expression of Survivin and Caspase-3 in primary ovarian carcinoma, and to explore their relationship. Methods The expression of Survivin and Caspase-3 was detected by flow cytometry (FCM) Results FCM showed that the expression of Survivin in ovarian serous carcinoma was higher than that in serous cystadenoma and normal ovarian tissues (F=19.80;P=0.00) and correlated with the clinical stage(t=-2.882, P=-0.009). The expression of Caspase-3 in ovarian serous carcinoma was higher than that in serous cystadenoma and normal ovarian tissues (F=16.32,P=0.00)and has no correlativity with clinical stage, histological grade, and lymph metastasis (P〉0.05). Survivin expression was negatively correlated with Caspase-3 expression in ovarian serous tumors (r=-0.43, P=0.029). Conclusion Survivin was negatively correlated with Caspase-3 in ovarian serous tumors.Combination of detecting the two protein expressions might be valuable in diagnosis and determining the malignant degree in ovarian serous carcinoma.
出处 《肿瘤研究与临床》 CAS 2012年第5期308-310,共3页 Cancer Research and Clinic
基金 基金项目:廊坊市科学技术研究与发展计划(2011013026)
关键词 卵巢肿瘤 SURVIVIN Caspase.3 流式细胞术 Ovarian neoplasms Survivin Caspase-3 Flow cytometry
  • 相关文献

参考文献5

二级参考文献32

  • 1Bo L, Yi M, Carolyn C, et al. Survivin as a therapeutic target for radiation sensitization in lung cancer[J]. Cancer Res, 2004, 64(15):2840-2845.
  • 2Ambrosini G, Adia C, Sirugo G, et al. Induction of apoptosis and inhibitor of cell prolifertion by gene targeting [J]. J Biol Chem, 1998,273(18):11177-11182.
  • 3Naka K, Iwamoto S, Gon G, et al. Expression of g and its relationship to loss of apoptosis in breast carcinomas[J]. Clin Cancer Res, 2000, 6(1):127-134.
  • 4Sarela A I, Macadam R C, Farmery S M, et al. Expression of the antiapoptosis gene, preedicts death from recurrent colorectal carcinoma[J].Gut, 2000, 46(5):645-650.
  • 5Ambrosini G, Adida C, Altieri D C. A novel antiapoptosis gene, expressed in cancer and lymphoma[J]. Nat Med, 1997, 3(8):917-921.
  • 6Deveravx Q L, Reed J C. TAP Family Proteins-suppressors of apoptosis[J]. Genes Dev, 1999, 13(3):239-252.
  • 7Kato J, Kuwabara Y, Mitani M, et al. Expression of g in esophageal cancer: correlation with the prognosis and response to chemotherapy[J]. Int J Cancer, 2001, 95(2): 92-95.
  • 8Ito T,Shiraki K,Sugimoto K,et al.Survivin promotes cell proliferation in human hepatocelluar carcinoma[J].Hepatology,2000,31 (5):1080 ~ 1085.
  • 9Caide Lu,Nobuhiko T.Spontaneous apoptosis is inversely related to intratumoral microvessel density in gastric carcinoma[J].Cancer Res,1997,57(2):221 ~224.
  • 10Adida C,Crotty PL,McGrath J,et al.Developmentally regulated expression of the novel cancer Anti-apoptosis gene survivin in human and mouse differentiation[J].AmJ pathol,1998,152 (1):43~ 49.

共引文献46

同被引文献15

  • 1韩丹(综述),叶胜龙(审校).Survivin与肿瘤转移[J].国际肿瘤学杂志,2007,34(5):333-335. 被引量:1
  • 2Adida C, Crotty PL, MeGraph J, et al. Developmentally regulated expression of the novel cancer anti-apoptosis gene survivin in human and mouse differentiation[J]. Am J Parhol, 1998, 152: 43-49.
  • 3Zhong H, Chiles K, Feldser D, et al. Modulation of hypoxia-inducible factor lalpha expression by the epidermal growth factor/phosphatidylinositol 3-kinase/PTEN/AKT/FRAP pathway in human prostate cancer cells: implications for tumor angiogenesis and therapeutics[J]. Cancer Res, 2000, 60: 1541-1545.
  • 4Shirai K, Suzyki Y, Oka K, et al. Nuclear survivin expression predicts poorer prognosis in glioblastoma [J]. Neurooncol, 2009, 91: 353-358.
  • 5Suzuki A, Hayashida M, Ito T, et al. Survivin initiates cell cycle entry by the competitive interaction with Cdk4/pl6(INK4a) and Cdk2/cyclin E complex activation[J]. Oncogene, 2000, 19: 3225-3234.
  • 6Ambrosini G, Adida G, Altieri DC. A novel anti-apoptosis gene, survivin expressed in cancer and lymphoma[J]. Nat Med, 1991, 3:917-921.
  • 7Shariat SF, Lotan Y, Saboofian H, et al. Survivin expression is associated with features of biologically aggressive prostate carcinoma [J]. Cancer, 2004, 100:751-757.
  • 8Semenza GL ,Wang GL. A nuclear factor induced by hypoxia via de novo protein synthesis binds to the human erythropoietin gene enhancer at a site required for transcriptional activation [J]. Mol Cell Biol, 1992, 12: 5447-5454.
  • 9Yang L, Cao Z, Li F, et al. Tumor specific gene expression using the Survivin promoter is further increased by hypoxia[J]. Gene Ther, 2004, 11: 1215-1223.
  • 10Zhu L, Fukuda S, Cordis G, et al. Anti-apoptotic protein Survivin plays a significant role in tubular morphogenesis of human coronary arteriolar endothelial cells by hypoxic preconditioning[J]. FEBS Lett, 2001, 508: 369-374.

引证文献1

二级引证文献7

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部